1-4 of 4
Sarvari Venkata Yellapragada, MBBS, MD
Close
Sort by
Journal Articles

Impact Of Revised-International Prognostic Scoring System (R-IPSS) Cytogenetic-Risk Stratification In Myelodysplastic Syndrome

Maria Otazo, Sarvari Venkata Yellapragada, MBBS, MD, Matthew Zheng, Ang Li, Ruben Hernandez Perez, Gustavo A. Rivero, MD
Journal: Blood
Blood (2013) 122 (21): 5234.
https://doi.org/10.1182/blood.V122.21.5234.5234
Published: 2013
Journal Articles

Intrinsic Biological Variability In High-Risk-Myelodysplastic Syndrome Impacts Overall Survival (OS) In Patients Experiencing Cytogenetic Evolution Treated With Azanucleosides

Ruben Hernandez Perez, Ang Li, Sarvari Venkata Yellapragada, MBBS, MD, Matthew Zheng, Maria Otazo, Martha Mims, MD, Gustavo A. Rivero, MD
Journal: Blood
Blood (2013) 122 (21): 1537.
https://doi.org/10.1182/blood.V122.21.1537.1537
Published: 2013
Journal Articles

Once a Week Bortezomib with Dexamethasone Is Effective with Limited Toxicity in Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities,

Nikhil C. Munshi, MD, Saem Lee, B.A., Suman Kambhampati, M.D., Michal Rose, M.D., Abid Mohiuddin, M.D., Yvonne Efebera, M.D., Andrew Han, B.A., Antoun Houranieh, RPh., M.S., Ph.D., Abraham Zimelman, M.D., Mary T. Brophy, M.D., Rao Prabhala, Ph.D., Terrence Grady, DO, PhD, Paulette Mehta, M.D, MPH, Teresa G Hayes, M.D., Sarvari Venkata Yellapragada, MBBS, MD, Caroline Behler, M.D., Catherine Klein, M.D., David Roodman, MD, PhD, Alan K. Lichtenstein, M.D.
Journal: Blood
Blood (2011) 118 (21): 3964.
https://doi.org/10.1182/blood.V118.21.3964.3964
Published: 2011
Journal Articles

Single Center Experience of Prognostic Factors and Survival Outcomes Among Veterans with MDS: A Retrospective Analysis

Premal D Lulla, MD, Sarvari Venkata Yellapragada, MBBS, MD, Zahida Yasin, MD, Carlos E. Arce-Lara, MD
Journal: Blood
Blood (2010) 116 (21): 4970.
https://doi.org/10.1182/blood.V116.21.4970.4970
Published: 2010